United States:
AstraZeneca Settles FCPA Case With SEC For $5.5M
09 September 2016
Fox Rothschild LLP
To print this article, all you need is to be registered or login on Mondaq.com.
Nevena Simidjiyska was featured in the Compliance
Week article, "AstraZeneca Settles FCPA Case With SEC for
$5.5M." View the full article.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Corporate/Commercial Law from United States
Corporate Transparency Act Update
Shulman Rogers
With the arrival of spring and the first set of Corporate Transparency Act (CTA) filing deadlines behind us, it is a good time for an update on lessons learned from the initial filings.
Compliance Isn't The Only 'AI Washing' Risk
Bracewell
Companies are rapidly adopting artificial intelligence technologies, and both regulators and private plaintiffs have set their sights on "AI washing," where businesses tout AI capabilities that do not exist.
